Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Pfizer has informed about the unaudited financial results for the quarter ended June 30, 2017, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 12:00 noon and concluded at 3:15 p.m.
The above information is a part of company’s filings submitted to BSE.